4-Hydroxyphenylpyruvate
Reactions involving 4-Hydroxyphenylpyruvate
Every recorded step where this molecule takes part
-
4-Hydroxyphenylpyruvate + O₂ → homogentisate + CO₂
-
L-tyrosine + α-ketoglutarate ⇌ 4-hydroxyphenylpyruvate + glutamate
Showing all 2 reactions.
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
Indole-3-acetic acid production is rare among gut bacteria and reflects OFOR-driven amino acid oxidation in acetogens.
DeFeo ME, Liu Y, Zhou Z, Higginbottom SK, Dodd D. · 2026-06-21
open access unreviewed -
2
Cardiovascular-kidney-metabolic syndrome through the lens of gut‑derived uremic toxins.
Xu C, Snelson M, Marques FZ. · 2026-06-15
open access unreviewed -
3
Systems engineering of <i>Escherichia coli</i> for high-level hydroxytyrosol production.
Zuo J, Zhang S, Huang W, Liu J, Gao C, Hu GP, Song W, Li X, Wei W, Wu J, Liu L, Liu K, Xu N. · 2026-06-01
open access unreviewed -
4
Heterologous expression of hydroxylase coupled with pathway optimization enables highly efficient ʟ-DOPA production in <i>Corynebacterium glutamicum</i>.
Jia M, Duan R, Jiang Y, Chu X, Wu X, Yang H, Ye B, Zhang B. · 2026-05-16
open access unreviewed -
5
Shikimate crosstalk enables record-level homogentisic acid production in <i>Yarrowia lipolytica</i>.
Xu C, Zhang W, Zhao Q, Lin X, Wang K, Wang M, Tan T. · 2026-04-15
open access unreviewed -
6
Hepatocellular carcinoma in a child with hereditary tyrosinemia type I despite early NTBC therapy: When should we suspect it?
Ouassou KL, Abilkassem R. · 2026-06-02
open access unreviewed -
7
High-yield production of hydroxytyrosol through metabolic engineering of <i>Yarrowia lipolytica</i>.
Chen B, Wang Y, Wang D, Wang Y, Liu X, Zhang G, Yang S. · 2026-02-21
open access unreviewed -
8
Flavonoid remodeling and functional characterization of CrHPPD during salt stress response in Carex rigescens.
Wu Y, Zhang J, Hu Q, Li Y, Li M, Sun Y. · 2026-07-24
unreviewed -
9
Shielding Metabolic Hotspots in the Triketone-Quinoline Scaffold Yields Potent 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors.
Li M, Xiao H, Zhou SM, Li ZX, Chen LJ, Wu L, Huang JJ, Kandegama W, Ismail I, Chen Q, Wang DW. · 2026-07-01
cited 1× unreviewed -
10
Interaction between lncRNAs and RNA binding proteins, and their potential as drug targets in the therapy of liver cancer (Review).
Liu J, Chen D. · 2026-05-21
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.